Rates of cBHT prescriptions are not yet being systemically tracked, and few data exist to demonstrate the safety, efficacy, or utility of the treatment.
Lifestyle modification and an individualized treatment approach are effective strategies for managing menopausal symptoms in breast cancer survivors who are largely advised to avoid hormone replacement therapy.
The Female Sexual Functioning Index was used to assess aspects of sexual function and experience in early postmenopausal women.
According to a study published in the Journal of Bone and Mineral Research, researchers hypothesized that serum K-Postn levels may be able to predict low-trauma fractures.
Intrarosa, the first FDA approved local, non-estrogen product for treating dyspareunia, is now available.
Although the updated statement does not change the recommendations outlined in previous treatment guidelines, the authors have added 8 new recommendations based on evidence that has emerged in the interim.
A combination of early menstruation with more frequent periods may lower a woman's depression risk.
Acute decline in ovarian function may contribute to the autoimmunity associated with rheumatoid arthritis.
The North American Menopause Society released updated guidelines for hormone therapy use in women who are postmenopausal.
Long-term denosumab increased bone mineral density in postmenopausal women.
Age significantly affected the association between hot flash status and flow-mediated dilation, particularly in younger women.
The fewer menstrual cycles women had over a lifetime placed them at greater risk for incident heart failure.
Research results indicate that more randomized clinical trials are needed to examine the relationship between hearing loss and oral hormone replacement therapy.
After 24 months, bone mineral density was statistically different from baseline.
Serum samples, spirometry, and questionnaire data were collected from nearly 1500 women to determine if menopausal status affected lung function.
Findings in postmenopausal women with T2DM; correlations prominent in those with higher 25(OH)D
Researchers examined body mass index differences in current, past, and never users of menopausal hormone therapy.
HRT in postmenopausal women was linked to lower CAC scores and a lower risk of long-term, all-cause mortality.
Severe anxiety was independently associated with poor quality of life in postmenopausal patients.
Data from the Nurses' Health Studies were analyzed to determine if there is a link between seropositive and seronegative rheumatoid arthritis and age of menopause onset.
For women with HIV, anti-Müllerian hormone is associated with age of menopause onset.
Women in the menopausal transition and early postmenopause are at higher risk for depressive symptoms and negative mood than those in late postmenopause.
Menopausal status is associated with accelerated lung function decline.
The FDA recently approved Intrarosa (prasterone) for moderate to severe pain during sexual intercourse due to menopause.
The use of menopausal hormone therapy was associated with improved bone mineral density and better bone microarchitecture.
Half of women treated with acupuncture report a decline in the frequency of menopausal vasomotor symptoms, according to a study published in Menopause.
Although a majority of women reported sexual satisfaction, many felt that it could improve.
Many women are able to adapt to the negative changes in sexual function that they experience as they age.
After 10 years follow-up, researchers found that women who experienced surgical menopause were more likely to suffer worse insomnia symptoms.
Nearly 2000 women underwent screening to determine if a link exists between depression or depressive symptoms and coronary artery disease.
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Improving Vascular Function in Pediatric T1D With Metformin
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation